298 related articles for article (PubMed ID: 34073805)
21. Native Mass Spectrometry, Ion Mobility, and Collision-Induced Unfolding for Conformational Characterization of IgG4 Monoclonal Antibodies.
Hernandez-Alba O; Wagner-Rousset E; Beck A; Cianférani S
Anal Chem; 2018 Aug; 90(15):8865-8872. PubMed ID: 29956914
[TBL] [Abstract][Full Text] [Related]
22. Intact quantitation of cysteine-conjugated antibody-drug conjugates using native mass spectrometry.
Li Y; Wang Y; Shenoy VM; Niu S; Jenkins GJ; Sarvaiya H
Rapid Commun Mass Spectrom; 2024 Aug; 38(15):e9774. PubMed ID: 38812280
[TBL] [Abstract][Full Text] [Related]
23. Agitation-Induced Aggregation of Lysine- And Interchain Cysteine-Linked Antibody-Drug Conjugates.
Johann F; Wöll S; Winzer M; Gieseler H
J Pharm Sci; 2024 May; 113(5):1265-1274. PubMed ID: 38070776
[TBL] [Abstract][Full Text] [Related]
24. Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody-Drug Conjugates Produced by AJICAP First Generation Technology.
Matsuda Y; Kliman M; Mendelsohn BA
J Am Soc Mass Spectrom; 2020 Jul; ():. PubMed ID: 32608232
[TBL] [Abstract][Full Text] [Related]
25. Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site.
Kumar A; Mao S; Dimasi N; Gao C
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961794
[TBL] [Abstract][Full Text] [Related]
26. Understanding the Effects of Site-Specific Light Chain Conjugation on Antibody Structure Using Hydrogen Exchange-Mass Spectrometry (HX-MS).
Karunaratne SP; Moussa EM; Mills BJ; Weis DD
J Pharm Sci; 2024 May; ():. PubMed ID: 38761863
[TBL] [Abstract][Full Text] [Related]
27. Distinctive Low-Resolution Structural Features of Dimers of Antibody-Drug Conjugates and Parent Antibody Determined by Small-Angle X-ray Scattering.
Law-Hine D; Rudiuk S; Bonestebe A; Ienco R; Huille S; Tribet C
Mol Pharm; 2019 Dec; 16(12):4902-4912. PubMed ID: 31618040
[TBL] [Abstract][Full Text] [Related]
28. Straightforward Glycoengineering Approach to Site-Specific Antibody-Pyrrolobenzodiazepine Conjugates.
Thompson P; Ezeadi E; Hutchinson I; Fleming R; Bezabeh B; Lin J; Mao S; Chen C; Masterson L; Zhong H; Toader D; Howard P; Wu H; Gao C; Dimasi N
ACS Med Chem Lett; 2016 Nov; 7(11):1005-1008. PubMed ID: 27882199
[TBL] [Abstract][Full Text] [Related]
29. Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation.
Matsuda Y; Malinao MC; Robles V; Song J; Yamada K; Mendelsohn BA
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121981. PubMed ID: 32036254
[TBL] [Abstract][Full Text] [Related]
30. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
Yamada K; Ito Y
Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
[TBL] [Abstract][Full Text] [Related]
31. Site-Specific Quantitation of Drug Conjugations on Antibody-Drug Conjugates (ADCs) Using a Protease-Assisted Drug Deconjugation and Linker-like Labeling (PADDLL) Method.
Yang X; Seol H; Lin W; Xu X; Shen B; Qiu H; Li N
Anal Chem; 2021 Jul; 93(27):9549-9558. PubMed ID: 34196532
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.
Matsuda Y; Robles V; Malinao MC; Song J; Mendelsohn BA
Anal Chem; 2019 Oct; 91(20):12724-12732. PubMed ID: 31478640
[TBL] [Abstract][Full Text] [Related]
33. Two-Dimensional Liquid Chromatography Coupled to High-Resolution Mass Spectrometry for the Analysis of ADCs.
Chapel S; Rouvière F; Sarrut M; Heinisch S
Methods Mol Biol; 2020; 2078():163-185. PubMed ID: 31643056
[TBL] [Abstract][Full Text] [Related]
34. Use of a charge reducing agent to enable intact mass analysis of cysteine-linked antibody-drug-conjugates by native mass spectrometry.
Pacholarz KJ; Barran PE
EuPA Open Proteom; 2016 Jun; 11():23-27. PubMed ID: 29900109
[TBL] [Abstract][Full Text] [Related]
35. Characterization and Higher-Order Structure Assessment of an Interchain Cysteine-Based ADC: Impact of Drug Loading and Distribution on the Mechanism of Aggregation.
Guo J; Kumar S; Chipley M; Marcq O; Gupta D; Jin Z; Tomar DS; Swabowski C; Smith J; Starkey JA; Singh SK
Bioconjug Chem; 2016 Mar; 27(3):604-15. PubMed ID: 26829368
[TBL] [Abstract][Full Text] [Related]
36. Site-Specific Antibody-Drug Conjugation Using Microbial Transglutaminase.
Dickgiesser S; Deweid L; Kellner R; Kolmar H; Rasche N
Methods Mol Biol; 2019; 2012():135-149. PubMed ID: 31161507
[TBL] [Abstract][Full Text] [Related]
37. Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assembly.
Farràs M; Miret J; Camps M; Román R; Martínez Ó; Pujol X; Erb S; Ehkirch A; Cianferani S; Casablancas A; Cairó JJ
MAbs; 2020; 12(1):1702262. PubMed ID: 31876436
[TBL] [Abstract][Full Text] [Related]
38. Effect of Linker-Drug Properties and Conjugation Site on the Physical Stability of ADCs.
Mills BJ; Kruger T; Bruncko M; Zhang X; Jameel F
J Pharm Sci; 2020 May; 109(5):1662-1672. PubMed ID: 32027921
[TBL] [Abstract][Full Text] [Related]
39. Hydrophobic interaction chromatography (HIC) method development and characterization of resolved drug-load variants in site-specifically conjugated pyrrolobenzodiazepine dimer-based antibody drug conjugates (PBD-ADCs).
Janaratne T; Wang XC; Becker C; Zhao Y; Leanna R; Pritts W
J Pharm Biomed Anal; 2020 Feb; 179():113027. PubMed ID: 31830625
[TBL] [Abstract][Full Text] [Related]
40. Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development.
Singh D; Dheer D; Samykutty A; Shankar R
J Control Release; 2021 Dec; 340():1-34. PubMed ID: 34673122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
